News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

On December 9, 2025, the RECOVER Initiative hosted the first webinar in a two-part series to help researchers use data from the initiative’s observational studies to advance Long COVID research. This webinar is part of the RECOVER Research Review (R3) Seminar Series, which brings the scientific community together to accelerate diagnosing, preventing, and treating Long COVID.
Biostatisticians and clinicians work together to help funded study teams access resources stored in RECOVER’s biorepository, a unique collection of biosamples from almost 30,000 adults and children.
This year, RECOVER researchers continue to publish results from research studies that deepen our understanding of Long COVID. RECOVER studies continue, with 2 clinical trials expected to reach enrollment goals this summer.
Using a large and diverse collection of tissue samples, experts in how diseases affect different parts of the body will explore the underlying causes of Long COVID.
RECOVER researchers at the University of New Mexico study site have built connections between RECOVER studies and the university’s Long COVID clinic to ensure patients have access to resources and care.
The journal PLOS ONE has published the full RECOVER study design for babies, children, adolescents, and young adults taking part in RECOVER studies.
Gary Gibbons, M.D., Walter Koroshetz, M.D., and Jeanne Marrazzo, M.D., M.P.H. of the NIH answer questions about investing an additional $515 million in RECOVER's Long COVID research efforts.
This additional funding will build on and continue RECOVER's work to improve our understanding of and ability to diagnose, prevent, and treat Long COVID.